The results of this study showed that 25, 100, 200 μM of Wogonin inhibited the levels of these inflammatory factors in U251 glioma cells, and the IL-1 and IL-6 levels decreased in a dose-dependent manner with the increase in Wogonin concentration. This evidence concerns the gene IL6 and central nervous system cancer.